3-amino-4-(5-ethylfuran-2-yl)-5,6,7,8,9,10-hexahydrocycloocta[b]thieno[3,2-e]pyridine-2-carboxamide

ID: ALA1091075

PubChem CID: 46884245

Max Phase: Preclinical

Molecular Formula: C20H23N3O2S

Molecular Weight: 369.49

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCc1ccc(-c2c3c(nc4sc(C(N)=O)c(N)c24)CCCCCC3)o1

Standard InChI:  InChI=1S/C20H23N3O2S/c1-2-11-9-10-14(25-11)15-12-7-5-3-4-6-8-13(12)23-20-16(15)17(21)18(26-20)19(22)24/h9-10H,2-8,21H2,1H3,(H2,22,24)

Standard InChI Key:  WFLFCWLGESAVJS-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 26 29  0  0  0  0  0  0  0  0999 V2000
   -3.6965   -3.0950    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6964   -2.2675    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1117   -1.6828    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1116   -3.6757    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2842   -3.6757    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2842   -1.6827    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7036   -2.2675    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7067   -3.0940    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9937   -3.5081    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9915   -1.8569    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2779   -2.2673    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2804   -3.0991    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5099   -3.3587    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    1.0010   -2.6872    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5141   -2.0128    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7714   -1.2289    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.8260   -2.6897    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2363   -3.4054    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.2407   -1.9765    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9920   -1.0319    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3300   -0.5467    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5854    0.2378    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4105    0.2373    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6648   -0.5475    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8959    0.9044    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5608    1.6583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  7  6  1  0
  6  3  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 11  1  0
  1  2  1  0
 15 16  1  0
  7  8  2  0
 14 17  1  0
  2  3  1  0
 17 18  2  0
  8  9  1  0
 17 19  1  0
  9 12  2  0
 10 20  1  0
 20 21  2  0
  1  4  1  0
 11 10  2  0
 10  7  1  0
 11 12  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 20  1  0
  4  5  1  0
 23 25  1  0
  5  8  1  0
 25 26  1  0
M  END

Associated Targets(Human)

EEF2K Tchem Serine/threonine-protein kinase EEF2K (1246 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 369.49Molecular Weight (Monoisotopic): 369.1511AlogP: 4.46#Rotatable Bonds: 3
Polar Surface Area: 95.14Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 4.45CX LogD: 4.45
Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.71Np Likeness Score: -1.37

References

1. Lockman JW, Reeder MD, Suzuki K, Ostanin K, Hoff R, Bhoite L, Austin H, Baichwal V, Adam Willardsen J..  (2010)  Inhibition of eEF2-K by thieno[2,3-b]pyridine analogues.,  20  (7): [PMID:20189382] [10.1016/j.bmcl.2010.02.005]

Source